Welcome to NDA’s free Breakfast seminar on Wednesday 20th March 08:30- 10:00 on Interactions with Agencies During Drug Development.
Rare Disease Day is NDA Groups' opportunity to show that we care passionately about this work and about getting treatments to the patients affected and to promote the vital work that is going on in this space by so many passionate patients, physicians and scientists.
NDAs Paul Chamberlain provides practical advice about how to present immunogenicity-related information in regulatory dossiers in the latest publication of Bioanalysis.
Welcome to NDA’s free Breakfast seminar in Munich, Germany, on Thursday 14th March 09:00- 10:30 on Immunogenicity for investigational biopharmaceutical products – Start with the goal in mind.
Kim Forbes-McKean PhD, joins NDA Group from a distinguished career spanning more than 30 years of leading research and development activities for large pharma, as well as small biotech companies.
Join us on Thursday 14th February for this engaging webinar with Thomas Lönngren, Strategic Advisor and Dr Brian Edwards, Principal Consultant about Brexit impact.
NDA will be presenting at Phacilitate, the world’s largest advanced therapies partnering event which will be held from 22nd – 25th January 2019.
Don't miss the opportunity to meet our Experts who will present on a number of critical drug development topics and be on hand to answer your questions.
In our fourth and last post leading up to the JP Morgan week all three of our NDA attendees share the most important reason that keeps them attending.
Our third reason in our series leading up to the JPM event is brought to us by Thomas Lönngren and talks about being in the right place at the right time!
Next in our short series leading up to the JPM event, we hear Johan Strömquist talk about his favourite aspects of the week and the reasons that keep him coming back for more!
On the 23rd January 2019 we invite you and your colleagues in the development & regulatory departments to a complimentary seminar on how to fully leverage on oral explanations and other opportunities to convince EU regulators.
The JP Morgan week in San Francisco in the early days of the New Year, known to some simply as “The Circus”, is one of the highlights of the year for those of us working in the life science industry. This is a week when drug developers, business folks, and investors get together to compare notes, strike deals, do business, and make new connections. In this short series leading up to the event itself, members of the NDA Group talk about their favourite aspects of the week and the reason that they keep coming back for more!